Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $258,463 | 97 | 68.3% |
| Consulting Fee | $47,886 | 24 | 12.7% |
| Food and Beverage | $29,709 | 1,076 | 7.9% |
| Travel and Lodging | $21,824 | 91 | 5.8% |
| Honoraria | $20,060 | 13 | 5.3% |
| Education | $505.60 | 11 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $131,601 | 225 | $0 (2024) |
| Celgene Corporation | $60,010 | 120 | $0 (2019) |
| Amgen Inc. | $48,444 | 72 | $0 (2024) |
| UCB, Inc. | $47,803 | 71 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $22,229 | 41 | $0 (2021) |
| Almirall LLC | $21,308 | 45 | $0 (2022) |
| LEO Pharma Inc. | $13,140 | 62 | $0 (2024) |
| Allergan, Inc. | $11,419 | 23 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $6,297 | 23 | $0 (2024) |
| EPI Health, LLC | $3,666 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113,489 | 225 | Galderma Laboratories, L.P. ($53,957) |
| 2023 | $76,293 | 213 | Galderma Laboratories, L.P. ($54,667) |
| 2022 | $31,613 | 135 | Galderma Laboratories, L.P. ($17,910) |
| 2021 | $23,919 | 156 | VYNE Pharmaceuticals Inc. ($12,921) |
| 2020 | $25,071 | 122 | Amgen Inc. ($13,102) |
| 2019 | $50,478 | 171 | Celgene Corporation ($31,808) |
| 2018 | $29,977 | 150 | Celgene Corporation ($12,950) |
| 2017 | $27,608 | 140 | Celgene Corporation ($15,252) |
All Payment Transactions
1,312 individual payment records from CMS Open Payments — Page 53 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/07/2017 | Valeant Pharmaceuticals North America LLC | — | Food and Beverage | In-kind items and services | $12.57 | General |
| 02/07/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: Immunology | ||||||
| 02/03/2017 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.39 | General |
| 02/02/2017 | Celgene Corporation | Otezla (Drug) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Dermatology | ||||||
| 02/02/2017 | Valeant Pharmaceuticals North America LLC | SOLODYN (Drug) | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: DERMATOLOGY | ||||||
| 02/01/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $100.05 | General |
| Category: Dermatology | ||||||
| 01/31/2017 | Galderma Laboratories, L.P. | ORACEA (Drug), MIRVASO, SOOLANTRA | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: ROSACEA | ||||||
| 01/26/2017 | Celgene Corporation | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Dermatology | ||||||
| 01/26/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $116.41 | General |
| Category: Dermatology | ||||||
| 01/24/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $13.53 | General |
| 01/11/2017 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: DERMATOLOGY | ||||||
| 01/07/2017 | Celgene Corporation | Otezla (Drug) | Education | In-kind items and services | $8.77 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,121 | 1,976 | $380,894 | $79,631 |
| 2022 | 12 | 1,082 | 1,890 | $298,456 | $83,556 |
| 2021 | 14 | 1,008 | 1,758 | $203,058 | $76,725 |
| 2020 | 11 | 952 | 1,632 | $181,580 | $60,744 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 307 | 383 | $99,274 | $20,115 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 169 | $61,448 | $12,809 | 20.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 89 | 142 | $45,350 | $10,112 | 22.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 168 | 241 | $46,076 | $8,906 | 19.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 113 | 125 | $36,010 | $7,673 | 21.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 22 | 23 | $19,600 | $4,652 | 23.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 120 | 706 | $13,226 | $3,304 | 25.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $16,827 | $3,075 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $11,060 | $2,514 | 22.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 19 | $9,123 | $2,321 | 25.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 48 | $7,761 | $1,661 | 21.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $9,029 | $1,197 | 13.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 19 | $2,736 | $673.99 | 24.6% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 13 | 13 | $3,374 | $618.42 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 275 | 344 | $70,600 | $20,100 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 183 | $52,910 | $15,690 | 29.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 84 | 128 | $32,422 | $9,486 | 29.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 122 | 136 | $32,051 | $9,151 | 28.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 165 | 240 | $37,228 | $8,704 | 23.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 18 | 19 | $12,594 | $3,824 | 30.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 18 | 28 | $10,927 | $3,378 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $14,512 | $3,347 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $13,096 | $3,065 | 23.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 113 | 613 | $9,268 | $2,923 | 31.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 56 | 61 | $7,103 | $1,945 | 27.4% |
About Dr. Joshua Grosshandler, M.D
Dr. Joshua Grosshandler, M.D is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2010. The National Provider Identifier (NPI) number assigned to this provider is 1023320389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Grosshandler, M.D has received a total of $378,447 in payments from pharmaceutical and medical device companies, with $113,489 received in 2024. These payments were reported across 1,312 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($258,463).
As a Medicare-enrolled provider, Grosshandler has provided services to 4,163 Medicare beneficiaries, totaling 7,256 services with total Medicare billing of $300,657. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 07/02/2010
- Last Updated 02/06/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1023320389
Products in Payments
- Otezla (Drug) $107,923
- AKLIEF (Drug) $53,010
- Bimzelx (Biological) $43,486
- EPSOLAY (Drug) $18,424
- Seysara (Drug) $14,749
- ZILXI (Drug) $12,921
- PICATO (Drug) $12,336
- AMZEEQ (Drug) $9,307
- ORACEA (Drug) $5,977
- SEYSARA (Drug) $5,174
- WYNZORA (Drug) $3,400
- ACZONE (Drug) $2,420
- RHOFADE (Drug) $2,133
- SKYRIZI (Biological) $1,150
- Sotyktu (Drug) $1,141
- DUPIXENT (Biological) $1,018
- Klisyri (Drug) $823.29
- Cimzia (Drug) $754.21
- TALTZ (Drug) $736.78
- RINVOQ (Biological) $723.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Jess Demaria, Md, MD
Dermatology — Payments: $195,915
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506
Sara Huff, Md, MD
Dermatology — Payments: $5,661